203 related articles for article (PubMed ID: 34427018)
1. Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm.
Chu R; Zhang Y; Qiao X; Xie L; Chen W; Zhao Y; Xu Y; Yuan Z; Liu X; Yin A; Wang Z; Zhang Q; Yang X; Su X; Kong B; Song K
Oncologist; 2021 Dec; 26(12):e2217-e2226. PubMed ID: 34427018
[TBL] [Abstract][Full Text] [Related]
2. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract][Full Text] [Related]
3. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Assessment of Cervical Cancer Patients by Clinical Staging and Surgical-Pathological Factor: A Support Vector Machine-Based Approach.
Xie L; Chu R; Wang K; Zhang X; Li J; Zhao Z; Yao S; Wang Z; Dong T; Yang X; Su X; Qiao X; Song K; Kong B
Front Oncol; 2020; 10():1353. PubMed ID: 32850433
[No Abstract] [Full Text] [Related]
5. Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028).
Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
Cancer Res Treat; 2020 Jan; 52(1):320-333. PubMed ID: 31401822
[TBL] [Abstract][Full Text] [Related]
6. The impacts of minimally invasive surgery on intermediate- or high-risk cervical cancer patients received adjuvant radiotherapy.
Zhang Q; Liu Z; Wang Y; Zhang J; Li W; Wang T; Wang J; Shi F; Su J
World J Surg Oncol; 2022 Nov; 20(1):372. PubMed ID: 36443879
[TBL] [Abstract][Full Text] [Related]
7. Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
Li X; Xu C; Yu Y; Guo Y; Sun H
BMC Cancer; 2021 Jul; 21(1):866. PubMed ID: 34320931
[TBL] [Abstract][Full Text] [Related]
8. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
10. A validation study of new risk grouping criteria for postoperative treatment in stage IB cervical cancers without high-risk factors: rethinking the Gynecologic Oncology Group criteria.
Chang SJ; Kim WY; Yoo SC; Yoon JH; Chun M; Chang KH; Ryu HS
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):91-6. PubMed ID: 19695765
[TBL] [Abstract][Full Text] [Related]
11. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy.
Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH
Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142
[TBL] [Abstract][Full Text] [Related]
12. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
13. A novel Silva pattern-based model for precisely predicting recurrence in intermediate-risk cervical adenocarcinoma patients.
Guo C; Tao X; Zhang L; Zhang Y; Hua K; Qiu J
BMC Womens Health; 2022 Sep; 22(1):377. PubMed ID: 36114524
[TBL] [Abstract][Full Text] [Related]
14. Preoperative fibrinogen-to-albumin ratio, a potential prognostic factor for patients with stage IB-IIA cervical cancer.
An Q; Liu W; Yang Y; Yang B
BMC Cancer; 2020 Jul; 20(1):691. PubMed ID: 32711484
[TBL] [Abstract][Full Text] [Related]
15. Role of Adjuvant Radiotherapy in Patients with Cervical Cancer Undergoing Radical Hysterectomy.
Alonso-Espías M; Gorostidi M; Gracia M; García-Pineda V; Diestro MD; Siegrist J; Hernández A; Zapardiel I
J Pers Med; 2023 Oct; 13(10):. PubMed ID: 37888097
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of consolidation chemotherapy after adjuvant therapy in stage IB-IIA cervical cancer patients with risk factors: a retrospective single-center study.
Wang J; Guo H; Yang J; Mao J; Wang Y; Gao R; Yan X; Wang J
Front Oncol; 2024; 14():1374195. PubMed ID: 38577338
[TBL] [Abstract][Full Text] [Related]
17. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
Paik ES; Lim MC; Kim MH; Kim YH; Song ES; Seong SJ; Suh DH; Lee JM; Lee C; Choi CH
Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
[TBL] [Abstract][Full Text] [Related]
18. Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB-IIA Lung Adenocarcinoma.
Zhai W; Gong L; Zheng Y; Yan Q; Lai R; Liang D; Wong W; Dai S; Wang J
Front Oncol; 2022; 12():851276. PubMed ID: 35402251
[TBL] [Abstract][Full Text] [Related]
19. A 5-gene DNA methylation signature is a promising prognostic biomarker for early-stage cervical cancer.
Chen H; Li H; Wang L; Li Y; Yang C
J Obstet Gynaecol; 2022 Feb; 42(2):327-332. PubMed ID: 34082663
[TBL] [Abstract][Full Text] [Related]
20. Impact of different postoperative adjuvant therapies on the survival of early-stage cervical cancer patients with one intermediate-risk factor: A multicenter study of 14 years.
Ye Y; Li Z; Kang S; Zhan X; Zhang Y; Xu Y; Li W; Lang J; Liu P; Chen C
J Obstet Gynaecol Res; 2023 Jun; 49(6):1579-1591. PubMed ID: 36916196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
